Ann Gils
- Genetics top 0.2%
- Inflammatory Bowel Disease 83
- Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms 58
- Immunology top 0.5%
- Immunodeficiency and Autoimmune Disorders 44
- Biosimilars and Bioanalytical Methods 33
- Epidemiology top 0.5%
- Microscopic Colitis 56
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms 52
-
- Monoclonal and Polyclonal Antibodies Research 28
-
- Systemic Lupus Erythematosus Research 17
- Co-authors
- Paul DeclerckSéverine VermeireNiels Vande CasteeleMarc FerranteGert Van AsschePaul RutgeertsGriet CompernolleThomas Van Stappen
- Cited by
- GeneticsHematologyImmunology
- Journals
- Journal of Thrombosis and Haemostasis (25 papers)Journal of Crohn s and Colitis (24 papers)Thrombosis and Haemostasis (14 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Ann Gils
218 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Genetics 4.0k
- Hematology 1.6k
- Immunology 2.8k
- Epidemiology 3.1k
- Cancer Research 1.3k
Countries citing papers authored by Ann Gils
This map shows the geographic impact of Ann Gils's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Gils with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Gils more than expected).
Fields of papers citing papers by Ann Gils
This network shows the impact of papers produced by Ann Gils. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Gils. The network helps show where Ann Gils may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann Gils, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2019 | 80 | |
| 3 | 2019 | 21 | |
| 4 | 2019 | 60 | |
| 5 | 2018 | 99 | |
| 6 | 2018 | 174 | |
| 7 | Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab. | 2018 | 7 |
| 8 | 2017 | 89 | |
| 9 | 2016 | 45 | |
| 10 | 2014 | 224 | |
| 11 | 2014 | 190 | |
| 12 | 2013 | 16 | |
| 13 | 2012 | 8 | |
| 14 | Determination of coagulation and fibrinolysis markers upon anti-TAFI treatment in a mouse thromboembolism model | 2011 | 1 |
| 15 | 2011 | 19 | |
| 16 | 2008 | 22 | |
| 17 | 2007 | 10 | |
| 18 | 2006 | 25 | |
| 19 | 2004 | 1 | |
| 20 | Substrate behavior of plasminogen-activator inhibitor-1 is not associated with a lack of insertion of the active-site loop | 1995 | 4 |
About Ann Gils
Ann Gils is a scholar working on Hematology, Cancer Research, Immunology, Genetics and Immunology and Allergy, having authored 222 papers that have together received 8.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (83 papers), Blood Coagulation and Thrombosis Mechanisms (58 papers), Microscopic Colitis (56 papers), Protease and Inhibitor Mechanisms (52 papers), Immunodeficiency and Autoimmune Disorders (44 papers), Biosimilars and Bioanalytical Methods (33 papers), Monoclonal and Polyclonal Antibodies Research (28 papers) and Systemic Lupus Erythematosus Research (17 papers). The work is most often cited by research in Genetics (4.0k citations), Hematology (1.6k citations), Immunology (2.8k citations), Epidemiology (3.1k citations) and Cancer Research (1.3k citations). Ann Gils has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Paul Declerck, Séverine Vermeire, Niels Vande Casteele, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Griet Compernolle, Thomas Van Stappen, Erwin Dreesen and Vera Ballet. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Journal of Crohn s and Colitis, Thrombosis and Haemostasis, Inflammatory Bowel Diseases and Clinical Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.